Can laser photocoagulation (laser treatment for retinal conditions) in the far periphery cause paracentral scotomas (areas of decreased vision)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Paracentral Scotomas After Peripheral Laser Photocoagulation

Yes, paracentral scotomas can occur after laser photocoagulation performed in the far periphery of the retina, as they are considered an anticipated side effect rather than a complication of the procedure. 1

Mechanism and Risk Factors

Laser photocoagulation works by destroying retinal tissue in targeted areas, which can affect visual function in those treated regions. Even when applied to the far periphery, several mechanisms can lead to paracentral scotomas:

  • Nerve fiber bundle damage: Laser treatment in the periphery can affect nerve fiber bundles that traverse through the treated area but originate from more central retinal locations 1, 2
  • Treatment location impact: While peripheral treatments typically result in minimal visual impact, the anatomical arrangement of nerve fibers means damage can manifest as paracentral visual field defects 1
  • Energy settings: Higher energy settings cause more permanent damage and potentially more persistent scotomas 1

Evidence and Prevalence

Studies have documented visual field changes following extensive photocoagulation:

  • Early research showed that patients undergoing extensive argon laser photocoagulation experienced various visual field changes, including discrete scotomata 2
  • Electroretinographic findings suggest that approximately 40% of the retinal area can be affected by extensive photocoagulation, predominantly in areas with high rod concentration 2

Clinical Presentation and Detection

Paracentral scotomas following peripheral laser treatment typically present as:

  • Areas of decreased vision often located temporally and/or inferiorly 3, 4
  • May appear similar to nerve fiber bundle defects 3
  • Can range in size from small (0.25°) to larger (4.0°) visual field defects 3
  • May be asymptomatic in some patients, especially when not involving fixation 1, 3

Monitoring and Management

For patients who have undergone peripheral laser photocoagulation:

  • Initial evaluation: Should be performed 3-4 months after photocoagulation, including:

    • Visual field testing
    • OCT imaging
    • Contrast sensitivity testing
    • Amsler grid screening 1
  • Follow-up: Consider OCT in 3-6 months to monitor for delayed structural changes 1

  • Red flags requiring urgent evaluation:

    • New symptoms or change in symptoms
    • Peripheral visual field loss beyond expected treatment areas
    • Decreased visual acuity not explained by the treatment
    • Development of subretinal fluid beyond the edge of treatment 1

Prognosis and Patient Education

  • Patients should be informed that paracentral scotomas are an expected side effect of photocoagulation 1
  • Conventional photocoagulation carries a risk of "symptomatic paracentral scotoma" which may persist but can show gradual reduction in size or intensity over 6-12 months 1
  • Alternative techniques like subthreshold diode laser photocoagulation or micropulse laser show better functional outcomes with less risk of persistent scotomas 1, 5

Prevention Strategies

To minimize the risk of paracentral scotomas:

  • Use minimum effective energy levels for photocoagulation 1
  • Carefully control power settings to minimize damage to surrounding tissues 1
  • Consider newer laser techniques (subthreshold or micropulse) which may reduce the risk of paracentral scotomas 1, 5

Patients undergoing peripheral laser photocoagulation should be counseled about the possibility of paracentral scotomas as part of the informed consent process, even when treatment is limited to the far periphery.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.